Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-06 4:15 pm |
N/A 2035-01-01 |
Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer |
197,000 | $0 | 197,000 (Direct) |
View |
| 2024-06-03 Option Award |
2024-06-05 4:10 pm |
N/A 2034-06-03 |
Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer |
40,000 | $0 | 40,000 (Direct) |
View |
Ownership |
2024-06-05 4:05 pm |
N/A 2030-08-14 |
Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer |
0 | $0 | 517,851 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:31 pm |
N/A 2033-01-02 |
Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Technology Officer |
78,550 | $0 | 78,550 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-02 6:46 pm |
N/A 2032-02-29 |
Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Technology Officer |
70,000 | $0 | 70,000 (Direct) |
View |
Ownership |
2021-06-23 8:32 pm |
N/A 2030-08-13 |
Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Technology Officer |
0 | $0 | 290,301 (Direct) |
View |